FT001

SKU: orb1700538

Description

FT001 is a potent, selective, and orally bioavailable BET bromodomain inhibitor with antitumor activity. It suppresses MYC expression (IC50 = 0.46 µM) and demonstrates potent antiproliferative effects against MV-4-11 cells, along with significant MYC mRNA suppression in both in vitro and in vivo models.

Research Area

Epigenetics & Chromatin

Key Properties

• CAS Number: 1778655-51-8
• MW: 467.58
• Purity: >99.99% (May vary between batches)
• Formula: C₂₅H₂₉N₃O₄S
• SMILES: C(=O)(N1C=2C(N(C(C)=O)[C@@H](C)C1)=CC=C(C2)C3=CC=C(C=C3)N4CCS(=O)(=O)CC4)C5CC5
• Target: Epigenetic Reader Domain
• Solubility: DMSO:45 mg/mL (96.24 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

FT001, FT-001, FT 001, Epigenetic Reader Domain, EpigeneticReaderDomain, BET bromodomain

Compound Identifiers

PubChem CID

118079501